Application 021375

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALAVERTLORATADINETABLET, ORALLY DISINTEGRATING;ORAL10MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021375-001ALAVERTLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d4dbc9d85df4…
2026-10-15 13:18:302026-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c2088c7a36db…
2026-09-14 22:38:342026-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1984e616aacf4f…
2026-08-18 06:07:402026-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1987673890dc5c…
2021-03-12 10:30 UTC2021-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f01610625f2…
2019-09-15 20:21 UTC2019-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b00525d2431f…
2019-07-19 19:46 UTC2019-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f0d92c62455…
2023-05-13 08:27 UTC2023-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19053a50430f4f…
2023-01-26 05:58 UTC2023-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 13 of 17 · 338 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LORATADINELORATADINEStrides Pharma Inc16ab6610-ac99-4714-848d-9377c6bca4592024-01-02WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINEStrides Pharma Inca54cdbe9-32ec-45ca-948f-9cefbb8e3cbf2024-01-02WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINETenshi Kaizen Pvt Ltdc20b916d-7dd0-1a56-e053-2995a90a3c1b2024-01-02WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEA-S Medication Solutions0f6fe391-8709-40f0-8f52-e3357e6ea4f92023-12-09WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEOHM LABORATORIES INC.c35f2cc1-f76d-4824-b0a5-747bca0c3b852023-12-08WarningsName fallback
generic name: LORATADINE
All Day Allergy ReliefLORATADINEDolgencorp, Inc. (DOLLAR GENERAL & REXALL)7eac9202-bd4c-4550-a257-2b8195a0dbcd2023-11-29WarningsName fallback
generic name: LORATADINE
Allergy ReliefLORATADINEAMERIFOODS TRADING COMPANYf6ce5292-f698-dd2f-e053-6394a90ad74a2023-11-02WarningsName fallback
generic name: LORATADINE
foster and thrive childrens allergy reliefLORATADINEStrategic Sourcing Services LLC5ac59de8-46ad-4731-8f98-167fb5f8b0892023-10-30WarningsName fallback
generic name: LORATADINE
All Day Allergy ReliefLORATADINEDolgencorp, Inc. (DOLLAR GENERAL & REXALL)9ea4fde8-e091-412d-9de1-dd66a2ab73e42023-10-26WarningsName fallback
generic name: LORATADINE
Loratadine ODTLORATADINEBetter Living Brands, LLCfad93257-bfcf-5e04-e053-6394a90a10a62023-09-25WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINECamber Consumer Care Incd57da4bd-af37-414a-a50c-e80d2bb283142023-09-08WarningsName fallback
generic name: LORATADINE
Equaline Childrens Allergy ReliefLORATADINEUnited Natural Foods, Inc. dba UNFI25329c7d-76e7-47b3-914e-ac367bbb750b2023-08-17WarningsName fallback
generic name: LORATADINE
Loratadine ODTLORATADINEAmerisource Bergend2524455-b6c4-442b-b139-666a555c52982023-07-10WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINEDr. Reddy's Laboratories Inc.d707733d-1ee9-92d3-f5b2-3567b9c217c22023-06-25WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINEDr. Reddy's Laboratories Inc.bb6af6a4-aec0-ddf5-57b7-063504ca8e1e2023-06-25WarningsName fallback
generic name: LORATADINE
topcare childrens allergy reliefLORATADINETopco Associates LLC4f7555ea-6286-4ff6-b125-d12660ae4bdf2023-06-20WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEPLD Acquisitions LLC DBA Avma Pharma Solutions2edb53f8-7661-4e54-bb50-e03078bae3bf2023-05-04WarningsName fallback
generic name: LORATADINE
childrens allergy reliefLORATADINERite Aid Corporationf8ddeb7e-94b1-4dce-815f-b6b8c71e88fd2023-04-13WarningsName fallback
generic name: LORATADINE
Claritin, BSX Non-Drowsy, 24 HourLORATADINELil' Drug Store Products, Incf85b0527-107c-4a4a-aad7-61d2f52bad632023-03-17WarningsName fallback
generic name: LORATADINE
Handy Solutions 24 Hour AllergyLORATADINENavajo Manufacturing Company Inc.67263031-9095-48f2-8b34-e589b28a74162023-03-15WarningsName fallback
generic name: LORATADINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0573-2620ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
80070-110AlavertLORATADINEFoundation Consumer BrandsNDACurrent
80070-120AlavertLORATADINEFoundation Consumer BrandsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
27639SUPPL2005-08-23
5224ORIG2004-05-26
42129ORIG2004-03-24
36796ORIG2003-04-09